These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 22750207)

  • 1. Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice.
    Halloran J; Hussong SA; Burbank R; Podlutskaya N; Fischer KE; Sloane LB; Austad SN; Strong R; Richardson A; Hart MJ; Galvan V
    Neuroscience; 2012 Oct; 223():102-13. PubMed ID: 22750207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.
    Spilman P; Podlutskaya N; Hart MJ; Debnath J; Gorostiza O; Bredesen D; Richardson A; Strong R; Galvan V
    PLoS One; 2010 Apr; 5(4):e9979. PubMed ID: 20376313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and enhancing NMDA signaling.
    Majumder S; Caccamo A; Medina DX; Benavides AD; Javors MA; Kraig E; Strong R; Richardson A; Oddo S
    Aging Cell; 2012 Apr; 11(2):326-35. PubMed ID: 22212527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy Dysfunction and mTOR Hyperactivation Is Involved in Surgery: Induced Behavioral Deficits in Aged C57BL/6J Mice.
    Jiang Y; Zhou Y; Ma H; Cao X; Li Z; Chen F; Wang H
    Neurochem Res; 2020 Feb; 45(2):331-344. PubMed ID: 31865521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.
    Van Skike CE; Jahrling JB; Olson AB; Sayre NL; Hussong SA; Ungvari Z; Lechleiter JD; Galvan V
    Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H693-H703. PubMed ID: 29351469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner.
    Holubova K; Kleteckova L; Skurlova M; Ricny J; Stuchlik A; Vales K
    Psychopharmacology (Berl); 2016 Jun; 233(11):2077-2097. PubMed ID: 27004790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease.
    Cassano T; Magini A; Giovagnoli S; Polchi A; Calcagnini S; Pace L; Lavecchia MA; Scuderi C; Bronzuoli MR; Ruggeri L; Gentileschi MP; Romano A; Gaetani S; De Marco F; Emiliani C; Dolcetta D
    Exp Neurol; 2019 Jan; 311():88-105. PubMed ID: 30243986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer's-like deficits in mice modeling the disease.
    Pierce A; Podlutskaya N; Halloran JJ; Hussong SA; Lin PY; Burbank R; Hart MJ; Galvan V
    J Neurochem; 2013 Mar; 124(6):880-93. PubMed ID: 23121022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways.
    Lesniewski LA; Seals DR; Walker AE; Henson GD; Blimline MW; Trott DW; Bosshardt GC; LaRocca TJ; Lawson BR; Zigler MC; Donato AJ
    Aging Cell; 2017 Feb; 16(1):17-26. PubMed ID: 27660040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR and autophagy in normal brain aging and caloric restriction ameliorating age-related cognition deficits.
    Yang F; Chu X; Yin M; Liu X; Yuan H; Niu Y; Fu L
    Behav Brain Res; 2014 May; 264():82-90. PubMed ID: 24525424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained high-fat diet modulates inflammation, insulin signalling and cognition in mice and a modified xenin peptide ameliorates neuropathology in a chronic high-fat model.
    Denver P; Gault VA; McClean PL
    Diabetes Obes Metab; 2018 May; 20(5):1166-1175. PubMed ID: 29316242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term ginsenoside Rg1 supplementation improves age-related cognitive decline by promoting synaptic plasticity associated protein expression in C57BL/6J mice.
    Yang L; Zhang J; Zheng K; Shen H; Chen X
    J Gerontol A Biol Sci Med Sci; 2014 Mar; 69(3):282-94. PubMed ID: 23833204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mTOR kinase via rapamycin blocks persistent predator stress-induced hyperarousal.
    Fifield K; Hebert M; Angel R; Adamec R; Blundell J
    Behav Brain Res; 2013 Nov; 256():457-63. PubMed ID: 24001755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial Effects of Early mTORC1 Inhibition after Traumatic Brain Injury.
    Nikolaeva I; Crowell B; Valenziano J; Meaney D; D'Arcangelo G
    J Neurotrauma; 2016 Jan; 33(2):183-93. PubMed ID: 26122481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression.
    Russo E; Leo A; Crupi R; Aiello R; Lippiello P; Spiga R; Chimirri S; Citraro R; Cuzzocrea S; Constanti A; De Sarro G
    J Psychiatr Res; 2016 Jul; 78():1-10. PubMed ID: 27019134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin extends murine lifespan but has limited effects on aging.
    Neff F; Flores-Dominguez D; Ryan DP; Horsch M; Schröder S; Adler T; Afonso LC; Aguilar-Pimentel JA; Becker L; Garrett L; Hans W; Hettich MM; Holtmeier R; Hölter SM; Moreth K; Prehn C; Puk O; Rácz I; Rathkolb B; Rozman J; Naton B; Ordemann R; Adamski J; Beckers J; Bekeredjian R; Busch DH; Ehninger G; Graw J; Höfler H; Klingenspor M; Klopstock T; Ollert M; Stypmann J; Wolf E; Wurst W; Zimmer A; Fuchs H; Gailus-Durner V; Hrabe de Angelis M; Ehninger D
    J Clin Invest; 2013 Aug; 123(8):3272-91. PubMed ID: 23863708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.
    Richardson A; Galvan V; Lin AL; Oddo S
    Exp Gerontol; 2015 Aug; 68():51-8. PubMed ID: 25481271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice.
    Hurez V; Dao V; Liu A; Pandeswara S; Gelfond J; Sun L; Bergman M; Orihuela CJ; Galvan V; Padrón Á; Drerup J; Liu Y; Hasty P; Sharp ZD; Curiel TJ
    Aging Cell; 2015 Dec; 14(6):945-56. PubMed ID: 26315673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-CSF and cognitive dysfunction in elderly diabetic mice with cerebral small vessel disease: Preventive intervention effects and underlying mechanisms.
    Guan ZF; Tao YH; Zhang XM; Guo QL; Liu YC; Zhang Y; Wang YM; Ji G; Wu GF; Wang NN; Yang H; Yu ZY; Guo JC; Zhou HG
    CNS Neurosci Ther; 2017 Jun; 23(6):462-474. PubMed ID: 28374506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin and mTOR inhibitors probably have therapeutic effects for post-operative cognitive dysfunction.
    Yang C; Zhu B; Shen J; Hu T; Li Z; Hong T
    Med Hypotheses; 2013 Sep; 81(3):487-8. PubMed ID: 23850396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.